Schering-Plough Corp (SGP)

MickeyJerry (39.31) Submitted: 10/07/06 11:34 PM : Start Price: $21.59 SGP Score: -3.75

SGP is a value play. The new CEO is promising.

Report this Post Replies: 0 | Reply | Permalink

SESAMEnow (60.51) Submitted: 3/31/08 1:57 PM : Start Price: $14.38 SGP Score: 26.06

Long shot but good return if it recovers. Worth the risk at this point to buy in.





Disclaimer: I do not have a position in this stock except as a minor part of a EFT ownership of 100 shares.

Report this Post Replies: 1 | Reply | Permalink

bemusic (< 20) Submitted: 3/31/08 10:49 PM : Start Price: $14.53 SGP Score: 25.73

Way oversold, should bounce... and be upgrades quick.

Report this Post Replies: 0 | Reply | Permalink

hoytw (88.43) Submitted: 3/31/08 11:26 PM : Start Price: $14.53 SGP Score: 25.73

Jim Kramer said it is under valued. Today cardiologist said to cut way back on the use of their heart drug and the stock fell.

Report this Post Replies: 0 | Reply | Permalink

DOUGE76 (21.73) Submitted: 10/07/06 12:38 PM : Start Price: $21.59 SGP Score: -3.75

1. successfully turnaround
2. Fred Hassan, excellent CEO
3. good balance sheet
4. introducing new, successful drugs

Report this Post Replies: 0 | Reply | Permalink

snappergrouper (31.93) Submitted: 10/05/06 12:10 PM : Start Price: $21.58 SGP Score: -3.68

buyout likely

Report this Post Replies: 0 | Reply | Permalink

1212chopcity (< 20) Submitted: 4/02/08 12:47 PM : Start Price: $14.15 SGP Score: 29.82

52 week low

Report this Post Replies: 0 | Reply | Permalink

juanocb12 (38.98) Submitted: 4/03/08 8:23 AM : Start Price: $13.97 SGP Score: 30.59

Went down becuase of the Vytorin. Sould go back up once it redevelops the formula. The good thing this incident is that it was a joint venture greatly minimizing risks.

Report this Post Replies: 0 | Reply | Permalink

xserver (65.04) Submitted: 4/04/08 12:06 PM : Start Price: $15.21 SGP Score: 23.26

Hey...just a hunch here!

Report this Post Replies: 0 | Reply | Permalink

Gedunken (28.64) Submitted: 3/31/08 11:28 AM : Start Price: $19.42 SGP Score: 1.94

Well, it appears that Merck and Schering-Plough were liars who withheld information for 2 years showing that Vytorin doesn't provide any reduction of risk for heart problems.

So, although this was a thumbs-up because I fully expected the meeting to ...

Report this Post Replies: 0 | Reply | Permalink